ESCRS - FP32.09 - Comparing Visual Performance And Bothersome Visual Disturbances Between A Diffractive And A Non-Diffractive Edof Intraocular Lens Using Minimonovision: A Prospective And Randomized Clinical Trial

Comparing Visual Performance And Bothersome Visual Disturbances Between A Diffractive And A Non-Diffractive Edof Intraocular Lens Using Minimonovision: A Prospective And Randomized Clinical Trial

Published 2023 - 41st Congress of the ESCRS

Reference: FP32.09 | Type: Free paper | DOI: 10.82333/radk-gs52

Authors: Andre Messias* 1 , Marcelo Caram 1

1Ophthalmology,FMRP-USP,Ribeirão Preto,Brazil

Purpose

To compare visual performance and bothersome visual disturbances of patients implanted with 2 different extended depth of focus (EDOF) intraocular lenses using mini-monovision.

Setting

Prospective, examiner-masked, randomized clinical trial.

Methods

Subjects with indication for bilateral cataract surgery, but no other eye disease, were assigned to either receive bilateral VIVITY or SYMFONY, with one eye targeted for slight myopia (-0.75 D). Comprehensive ophthalmological examination along with defocus curve, contrast sensitivity (Pelli-Robson), reading speed, patient-reported spectacle independence questionnaire (PRSIQ), and a quality of Vision (QoV) questionnaire were recorded at 3 months after surgeries.

Results

126 patients finished the follow-up: group VIVITY: n= 66; SYMFONY: n=60. Binocular uncorrected 20/20 distance visual acuity (VA) was achieved in 64 (97%) patients in group VIVITY and in 58 (97%) from SIMFONY (P =0.7244). Mean (logMAR) binocular far uncorrected VA was VIVITY: -0.02±0.01 (20/19) and SIMFONY: -0.03±0.01 (20/19) (P=0.4003). Uncorrected binocular near VA was Jaeger 2 or better (20/20) in 63 (95%) and 56 (93%) patients for VIVITY and SYMFONY respectively (P=0.9351). There was no significant between-groups differences regarding contrast sensitivity, reading speed or PRSIQ, but there was a significant lower probability for patients complaining of bothersome visual disturbances with VIVITY (35%) than with SIMFONY (55%) (P=0.0226).

Conclusions

Mini-monovision is well tolerated in patients with  both EDOF lenses. In these cohort, VIVITY performed similarly to SYMFONY, but these data indicate that VIVITY has lower probability of bothersome visual disturbance.